Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Metabiologics
AddedFeb 13, 2024
UpdatedJun 28, 2026
Metabiologics

Metabiologics

Operating

Metabiologics Inc: A venture capital-funded biotech firm, producing vaccines since 1999.

Location
Madison, WI, US
Founded
2000
Firm
Compare
Portfolio
Employees
Website

Metabiologics is a venture capital-funded biotech firm that has been producing bacterial and virus vaccines, including botulinum toxins, since 1999. Located in the University of Wisconsin Research Park in Madison, Wisconsin, the firm focuses on manufacturing high-purity toxin products for accredited researchers globally. Metabiologics typically invests in a range of stages, including Seed, Series A, and Series B rounds, with a significant number of investments also in debt financing and angel rounds.

The firm's portfolio includes notable companies such as Agricycle Global, AIQ Solutions, and AquaMost. Metabiologics is led by key partners with extensive experience in the biotech sector, ensuring a robust investment philosophy centered on innovation and industry standards. The firm offers unique value-add services such as customized product specifications and order quantities, enhancing the capabilities of its portfolio companies.

Metabiologics - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments96
Current Portfolio Count48
Total Portfolio Exits1

Top Investment Stages

Series Unknown35 (40.7%)
Seed27 (31.4%)
Series A12 (14.0%)
Debt Financing6 (7.0%)
Series B6 (7.0%)

Stage Mix

Series Unknown 41%Seed 31%Series A 14%Debt Financing 7%Series B 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Midwest Games logo

Midwest Games

Flyte logo

Flyte

Beereaders logo

Beereaders

Transportant logo

Transportant

Frontdesk logo

Frontdesk

Sequoir logo

Sequoir

Nurse Disrupted logo

Nurse Disrupted

Immuto Scientific logo

Immuto Scientific

Akru logo

Akru

Agricycle Global logo

Agricycle Global

OnLume logo

OnLume

C. Light Technologies logo

C. Light Technologies

Carson Life logo

Carson Life

Momi Brands logo

Momi Brands

LÜM logo

LÜM

AIQ Solutions logo

AIQ Solutions

Prism.fm logo

Prism.fm

ImageMoverMD logo

ImageMoverMD

SimpleMachines logo

SimpleMachines

Shine Medical Technologies logo

Shine Medical Technologies

EnsoData logo

EnsoData

Bundlar logo

Bundlar

Invenra logo

Invenra

Fetch logo

Fetch

Madison Vaccines logo

Madison Vaccines

Metabiologics - Classification

Also Known As
  • Wisconsin Investment Partners LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 7210Research and experimental development on natural sciences and engineering
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 523910Miscellaneous Intermediation
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 6000Depository Institutions
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 6720Investment Offices
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 6722Management Investment Offices, Open-end
  • 8731Commercial Physical and Biological Research